Research advances in immune tolerance of allogeneic cell transplantation in preterm infants.
- Author:
Can LYU
1
;
Yi QU
;
De-Zhi MU
Author Information
1. Department of Pediatrics, West China Second University Hospital/Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China. quyi712002@163.com.
- Publication Type:Journal Article
- MeSH:
Apoptosis;
Cell Transplantation;
adverse effects;
Cytokines;
physiology;
Graft vs Host Reaction;
Humans;
Immune Tolerance;
Infant, Newborn;
Infant, Premature;
immunology;
Transplantation, Homologous
- From:
Chinese Journal of Contemporary Pediatrics
2018;20(4):338-340
- CountryChina
- Language:Chinese
-
Abstract:
Preterm infants are a special group, and related severe neurological, respiratory, and digestive disorders have high disability/fatality rates. Allogeneic cell transplantation may be an effective method for the prevention and treatment of these diseases. At present, animal studies have been conducted for allogeneic cell transplantation in the treatment of hypoxic-ischemic encephalopathy, bronchopulmonary dysplasia, and necrotizing enterocolitis. The main difficulty of this technique is graft-versus-host reaction (GVHR), and successful induction of immune tolerance needs to be achieved in order to solve this problem. This article reviews the research advances in immune tolerance of allogeneic cell transplantation in preterm infants.
